MMTV‐Neu mice have been used for modeling epidermal growth factor receptor 2 (HER2)‐positive breast cancer, whereas MMTV‐CyclinD1 for estrogen receptor (ER)‐positive breast cancer. Here, CCND1 is linked to breast cancer.